Dr. Daniel Kraft
Fee Range$25K - $40K
Travels FromLos Angeles, CALIFORNIA
At a glance:Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Daniel Kraft explores the impact and potential of rapidly developing technologies as applied to health and medicine.
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as Faculty Chair for Medicine at Singularity University since its inception in 2008, and is the Founder and Chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.
Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children’s Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford.
He has multiple scientific publications and medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California San Francisco.
Daniel’s academic research has focused on: stem cell biology and regenerative medicine, stem cell derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. Clinical work focuses on: bone marrow / hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell based regenerative medicine, including marrow derived stem cell harvesting, processing and delivery. He also implemented the first text-paging system at Stanford Hospital.
He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable stem cell-based regenerative therapies. He is also the founder of IntelliMedicine, focused on data driven, precision medicine.
Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 Fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.
Medicine's future? There's an app for thatDaniel Kraft offers a fast-paced look at the next few years of innovations in medicine, powered by new tools, tests and apps that bring diagnostic information right to the patient's bedside.
The Intelligent, Proactive Future of MedicineFrom Artificial Intelligence (A.I.) to Intelligence Augmentation (I.A.): This talk will explore the cutting edge and potential for intelligent technologies to reshape the future of medicine. Healthcare is still based on intermittent data and a reactive 'sickcare' mindset. With the explosion of new data sources, ranging from personal 'omics, to wearable digital health exhaust and IoT... AI & Machine Learning has the potential to catalyze far more continuous, proactive and personalized healthcare.
The Future of Health and Medicine: Where Can Technology Take Us?From the perspective of a physician-scientist, inventor and innovator, this talk examines rapidly emerging, game-changing and convergent technology trends, and how they are and will be leveraged to change the face of healthcare and the practice of medicine in the next decade
A deep dive into where emergent fields such as low cost personal genomics, the digitization of health records, crowd sourced data, molecular imaging, wearable devices & mobile health, synthetic biology, robotics, artificial intelligence, 3D printing and regenerative medicine are transforming healthcare, and have the potential to enable clinicians, empower patients and deliver better care and outcomes at lower cost.
We’d like to take this opportunity to offer our sincere thanks for joining us in Basel and for presenting to our Novartis colleagues during the Global CSO Meeting last week. Your presentation provided vital insights into what the future of our industry might look like and allowed us to consider how we are going to ensure we are fully involved in a new era of digital medicine. We have had excellent feedback from the meeting delegates, who feel inspired and motivated by your presentation, and we are all looking forward to seeing how the future of digital medicine takes shape; and of course, our contributions towards it!
—Novartis Pharma AG
What a treat. Thank you for your time and the energy you brought to The Nantucket Project. We were lucky to have you. I have received such incredible feedback. We are so lucky that people like you agree to come and give so much. The audience loved you and it was a great blend with other presenters and conversation throughout the weekend. I am very grateful. Voices like yours and the role you play in the world are vital.
—The Nantucket Project